Revolutionizing the treatment of memory loss

We’re passionate about improving the quality of life for our aging population.

Who are we ?

Casp-Aid Inc. is a biotechnology startup company based in Montreal. We are driven to revolutionize the treatment of memory loss in aging populations through a novel approach based on over 30 years of research. 

We are committed to finding a treatment that not only prevents or delays memory impairment but normalizes memory function.

COGNITIVE IMPAIRMENT AFFECTS MANY INDIVIDUALS

10-15% convert to dementia yearly.

Affects non-Alzheimer individuals.

First symptom of Alzheimer desease.

Negative social, economic, financial impact.